We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
New Targeted Therapies for Metastatic Colorectal Cancer Recommended in the Updated NCCN Guideline.
- Authors
Kuznar, Wayne
- Abstract
The article focuses on updated National Comprehensive Cancer Network (NCCN) guideline for metastatic colorectal cancer (CRC). It mentions first-line immunotherapy options for patients with mismatch repair deficiency (dMMR) and microsatellite instability-high (MSI-H) CRC are also listed in new guideline. It mentions first-line bevacizumab added to chemotherapy has improved the median overall survival compared with chemotherapy alone in phase 3 clinical trials of patients with metastatic CRC.
- Subjects
COLORECTAL cancer; METASTASIS; GUIDELINES; RAS oncogenes; VASCULAR endothelial growth factor receptors
- Publication
Oncology Practice Management, 2019, Vol 9, Issue 7, p1
- ISSN
2164-4403
- Publication type
Article